Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Corcept Therapeutics Company Profile (NASDAQ:CORT)

Consensus Ratings for Corcept Therapeutics (NASDAQ:CORT) (?)
Ratings Breakdown: 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $3.83 (58.06% upside)

Analysts' Ratings History for Corcept Therapeutics (NASDAQ:CORT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/1/2014Brinson PatrickInitiated CoverageOutperform$8.00ViewTweet This Rating  Share This Rating on StockTwits
1/13/2014Stifel NicolausDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
8/9/2013Ladenburg ThalmannDowngradeBuy -> Neutral$3.30ViewTweet This Rating  Share This Rating on StockTwits
8/9/2013Janney Montgomery ScottDowngradeBuy -> Neutral$3.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
8/9/2013Credit SuisseDowngradeOutperform -> Neutral$4.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2013Piper JaffrayDowngradeOverweight -> Neutral$4.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Piper JaffrayUpgradeUnderweight -> OverweightViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Janney Montgomery ScottInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/10/2012Cowen and CompanyDowngradeOutperform -> NeutralViewTweet This Rating  Share This Rating on StockTwits
11/13/2012Credit SuisseInitiated CoverageOutperform$4.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2012Piper JaffrayDowngradeNeutral -> Underweight$3.00 -> $1.10ViewTweet This Rating  Share This Rating on StockTwits
11/2/2012OppenheimerDowngradeOutperform -> PerformViewTweet This Rating  Share This Rating on StockTwits
9/13/2012Piper JaffrayDowngradeOverweight -> NeutralViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2012 forward)